Advisory Board

Shaping the future of neurodiagnostics alongside leading experts

 

Industry solutions often miss practical constraints of real-world care. At Natus, we know for technology to be truly effective; it must be shaped by the clinicians who use it—strengthening the connection between clinical experience and patient access, experience, and outcomes. 

 
We believe clinical reality, shaped by the needs of the clinicians delivering care every day, should guide how neurodiagnostic solutions evolve. 

 

The Natus Advisory Board brings together a distinguished group of clinical leaders in neurodiagnostic care working closely with us to shape how technology continues to evolve in practice— now and in the future. 

EEG Advisory Board

 

Why an advisory board?

Our work with neurologists, epileptologists, neurointensivists and other leading clinicians is grounded in impactful collaboration to design solutions that are clinically meaningful, not just technically possible​:

  • Clinician insights that guide innovation from the very start
  • Ongoing dialogue, not just one-time reviews
  • A focus on real-world workflows

The EEG Advisory Board reflects Natus’ commitment to advancing neurodiagnostic care through collaboration, innovation, and clinical partnership and to keeping clinical reality at the center of how EEG evolves. Insights from the board will inform product development, clinical research initiatives, and global education programs. Together, we are committed to helping clinicians achieve the highest quality patient care possible.

 

 

Who is involved?

The Natus EEG Advisory Board is comprised of a global, cross-disciplinary group of EEG leaders representing: 

  • Neurology, neurophysiology, and critical care specialties 
  • Diverse care settings, from large academic centers to community hospitals
  • Regions across the Americas, Europe, and Asia-Pacific

Together, they bring bring deep clinical experience, leading-edge research insights, and a wide range of real-world perspectives. “The Natus EEG Advisory Board represents a crucial bridge where clinicians are part of the innovation process creating more effective technologies to better patient outcomes.”  – Dr. Brian Litt, US EEG Advisory Board Chair

 

 

Focus areas

The advisory board will shape key areas of EEG innovation, including:

  • AI-enabled interpretation and clinical decision support 
  • Workflow efficiency and reduced clinician burden 
  • Expanded access to EEG, including point-of-care technologies
  • Support for care across diverse and resource-limited settings
  • Digital transformation

These priorities reflect the real scenarios clinicians face every day, and where meaningful progress is needed most. 

We are seeing rapid advances in data acquisition, signal processing, and artificial intelligence. The opportunity now is to translate those advances into tools that truly improve care at the bedside. This advisory board brings together clinicians who understand both the promise and the realities of clinical practice, and who are committed to helping shape solutions that will make a meaningful difference for patients.

Dr. Brian Litt

US EEG Advisory Board Chair | Neurologist, researcher, and Professor of Neurology and Bioengineering at the University of Pennsylvania